| Literature DB >> 30374316 |
Hoda Badr1, Krista Herbert2, Mark D Bonnen3, Joshua A Asper3, Timothy Wagner3.
Abstract
Background: Head and neck cancer (HNC) adversely affects the psychological (i.e., depression, anxiety) and marital adjustment of patients and their spouses. Dyadic coping refers to how couples cope with stress. It includes positive actions like sharing practical or emotional concerns (i.e., problem- and emotion-focused stress communication; PFSC, EFSC), and engaging in problem- or emotion-focused actions to support each other (problem- and emotion-focused dyadic coping; PFDC, EFDC). It also includes negative actions like avoidance (negative dyadic coping; NEGDC). In this secondary analysis of a randomized pilot trial of a couple-based intervention called SHARE (Spouses coping with the Head And neck Radiation Experience), we first examined associations between patients' and spouses' dyadic coping (and satisfaction with dyadic coping; SATDC) and their own/each other's psychological and marital adjustment. Next, we examined the effects of SHARE relative to usual medical care (UMC) on patients' and spouses' dyadic coping. Finally, we examined whether changes in dyadic coping were associated with changes in patients' and spouses' psychological and marital adjustment. Methods and Measures: Thirty HNC patients (80% men) and their spouses (N = 60) completed baseline surveys prior to initiating radiotherapy (RT) and were randomized to SHARE or UMC. One month after RT, they completed follow-up surveys.Entities:
Keywords: caregiving; couples; depression; dyadic adjustment; dyadic coping; head and neck cancer; psychosocial intervention; radiotherapy
Year: 2018 PMID: 30374316 PMCID: PMC6196240 DOI: 10.3389/fpsyg.2018.01780
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Baseline correlations and descriptive results (N = 30 patients and 30 caregivers).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Patients Mean ( | Spouses Mean ( | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. PFSC | 0.73∗∗ | 0.38∗ | 0.57∗∗ | 0.11 | 0.56∗∗ | −0.45∗ | −0.23 | 0.41∗ | 0.12 | 3.93 (0.70) | 3.35 (0.99) | 2.81∗∗ | |
| 2. EFSC | 0.62∗∗ | 0.40∗ | 0.80∗∗ | 0.28 | 0.65∗∗ | −0.35 | 0.02 | 0.22 | −0.11 | 3.27 (1.00) | 2.72 (0.99) | 2.70∗∗ | |
| 3. PFDC | 0.18 | −0.03 | 0.44∗ | 0.19 | 0.03 | −0.18 | 0.09 | 0.48∗∗ | −0.07 | 3.62 (0.91) | 3.67 (0.95) | −0.27 | |
| 4. EFDC | 0.48∗∗ | 0.49∗∗ | 0.39∗ | 0.08 | 0.72∗∗ | −0.36 | 0.19 | 0.40 | −0.22 | 3.93 (1.12) | 4.10 (1.05) | −1.27 | |
| 5. NegDC | −0.48∗∗ | −0.14 | −0.12 | −0.11 | 0.20 | 0.19 | 0.11 | −0.46 | 0.07 | 1.57 (0.81) | 1.57 (0.72) | 0 | |
| 6. SatDC | 0.55∗∗ | 0.40∗ | 0.39∗ | 0.81∗∗ | 0.45 | −0.40∗ | −0.13 | 0.01 | 0.01 | 4.27 (1.05) | 3.93 (1.14) | 2.16∗ | |
| 7. PROMIS depression raw score | −0.29 | −0.10 | −0.01 | 0.36 | 0.19 | 0.05 | 0.41∗ | −0.35 | −0.05 | 9.27 (3.31) | 12.40 (5.87) | −2.40∗ | |
| 8. PROMIS anxiety raw score | −0.12 | 0.10 | −0.11 | 0.09 | 0.15 | −0.27 | 0.53∗∗ | 0.11 | −0.68∗∗ | 11.53 (4.17) | 13.00 (4.97) | −1.66 | |
| 9. DAS-7 | 0.30 | 0.12 | 0.22 | 0.10 | −0.32 | 0.29 | −0.10 | −0.08 | −0.11 | 28.80 (4.01) | 27.57 (5.28) | 1.39 | |
| 10. Age | 0.11 | −0.05 | −0.25 | −0.20 | 0.07 | −0.04 | −0.44∗∗ | −0.28 | −0.10 | 58.43 (10.49) | 58.07 (10.11) | 0.52 |
Baseline and follow-up means and SDs for stress communication and dyadic coping for patients and spouses in the SHARE intervention and UMC.
| Patients | Spouses | |||||||
|---|---|---|---|---|---|---|---|---|
| SHARE | UMC | SHARE | UMC | |||||
| Baseline M ( | Follow-up M ( | Baseline M ( | Follow-up M ( | Baseline M ( | Follow-up M ( | Baseline M ( | Follow-up M ( | |
| PFSC | 3.93 (0.73) | 4.27 (0.90) | 3.93 (0.70) | 3.53 (1.16) | 3.30 (1.18) | 3.83 (1.04) | 3.40 (0.81) | 2.93 (0.90) |
| EFSC | 3.50 (0.73) | 3.57 (0.84) | 3.03 (1.20) | 3.07 (1.13) | 2.90 (0.93) | 3.27 (0.88) | 2.53 (1.04) | 2.47 (1.04) |
| PFDC | 3.77 (1.00) | 3.73 (1.02) | 3.47 (0.81) | 3.00 (0.91) | 3.90 (0.85) | 4.13 (0.81) | 3.43 (1.02) | 3.03 (1.06) |
| EFDC | 4.27 (0.73) | 4.38 (0.64) | 3.49 (1.33) | 3.64 (1.14) | 4.44 (0.66) | 4.49 (0.79) | 3.76 (1.26) | 3.58 (1.22) |
| NEGDC | 1.73 (1.02) | 1.80 (1.05) | 1.40 (0.51) | 1.97 (0.77) | 1.60 (0.83) | 1.47 (0.64) | 1.53 (0.61) | 2.17 (1.21) |
| SATDC | 4.47 (0.64) | 4.87 (0.52) | 4.07 (1.34) | 3.87 (1.30) | 3.93 (1.03) | 4.27 (0.88) | 3.93 (1.28) | 3.60 (1.18) |
ANCOVA results for dyadic coping at baseline (T0) and at 1-month follow-up (T1).
| Treatment group | |||
|---|---|---|---|
| Measure at T1 | Least square means | ||
| PFSC | 16.29 | <0.0001 | UMC = 3.20, SHARE = 4.08 |
| EFSC | n.s. | n.s. | – |
| PFDC | 6.29 | 0.02 | UMC = 3.20; SHARE = 3.75 |
| EFDC | n.s. | n.s. | – |
| NEGDC | 5.60 | 0.02 | UMC = 2.16; SHARE = 1.54 |
| SATDC | 13.38 | 0.001 | UMC = 3.81; SHARE = 4.49 |